Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: A prospective multi-center study

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Gez, Eliahu ^a   Cytron, Shmuel ^a   Yosef, Rahamin Ben ^a   London, Daniel ^a   Corn, Benjamin W ^a   Alani, Shlomi ^a   Scarzello, Giovanni ^a   Dal Moro, Fabrizio ^a   Sotti, Guido ^a   Zattoni, Filiberto ^a   Koziol, Ike ^a   Torre, Taryn ^a   Bassignani, Matthew ^a   Kalnicki, Shalom ^a   Ghavamian, Reza ^a   Blakaj, Dukagjin ^a   Anscher, Mitchell ^a   Sommerauer, Martin ^a   Jocham, Dieter ^a   Melchert, Corinna ^a   Huttenlocher, Stefan ^a   Kovacs, Gyoergy ^a   Garg, Madhur ^a   more..

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Implantable biodegradable balloon; Prostate radiotherapy; Prostate rectum separation

Indexed keywords

ARTICLE; BALLOON; BLADDER CATHETERIZATION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DOSIMETRY; DYSURIA; EQUIPMENT FAILURE; ERECTILE DYSFUNCTION; FATIGUE; HISTOGRAM; HUMAN; IMPLANT; IMPLANTABLE BIODEGRADABLE BALLOON; INTENSITY MODULATED RADIATION THERAPY; MALE; MULTICENTER STUDY; NOCTURIA; OCCULT BLOOD; PENILE BLEEDING; PROCTITIS; PROSPECTIVE STUDY; PROSTATE CANCER; PRURITUS; RADIATION DOSE; RADIATION PROTECTION; RECTUM; SCAR; SIMULATION; SKIN PAIN; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT DURATION; TREATMENT PLANNING; URINE INCONTINENCE; URINE RETENTION; AGED; BIODEGRADABLE IMPLANT; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; MIDDLE AGED; PROSTATIC NEOPLASMS;

ABSORBABLE IMPLANTS; AGED; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM;

EID: 84876712945     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-96     Document Type: Article

References (21)

1. Martinez AA, Gonzalez J, Ye H, Ghilezan M, Shetty S, Kernen K, Gustafson G, Krauss D, Vicini F, Kestin L. Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer pts treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys 2011, 79:363-70. 10.1016/j.ijrobp.2009.10.035, 21195875.
2. Zelefsky MJ, Pei X, Chou JF, Schechter M, Kollmeier M, Cox B, Yamada Y, Fidaleo A, Sperling D, Happersett L, Zhang Z. Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes. Eur Urol 2011, 60:1133-9. 10.1016/j.eururo.2011.08.029, 21889832.
3. Prada PJ, Mendez L, Fernández J, González H, Jiménez I, Arrojo E. Long-term biochemical results after high-doserate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer. Radiat Oncol 2012, 7:31-38. 10.1186/1748-717X-7-31, 3310720, 22397528.
4. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1124-9. 10.1016/j.ijrobp.2007.11.044, 18313526.
5. Dolezel M, Odrazka K, Vaculikova M, Vanasek J, Sefrova J, Paluska P, Zouhar M, Jansa J, Macingova Z, Jarosova L, Brodak M, Moravek P, . Hartmann Dose Escalation in Prostate Radiotherapy up to 82Gy Using Simultaneous Integrated Boost Direct Comparison of Acute and Late Toxicity with 3D-CRT 74Gy and IMRT 78Gy. Strahlenther Onkol 2010, 186:197-202. 10.1007/s00066-010-2065-x, 20354663, Hartmann.
6. Syndikus IMorgan RC Syndikus I, Morgan RC, Sydes MR, Graham JD, Dearnaley DP. MRC RT01 collaborators: Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397). Int J Radiat Oncol Biol Phys. 2010, 77:773-83. 10.1016/j.ijrobp.2009.05.052, 2937212, 19836155.
7. Gill S, Thomas J, Fox C, Kron T, Rolfo A, Leahy M, Chander S, Williams S, Tai KH, Duchesne GM. Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol 2011, 6:145-15. 10.1186/1748-717X-6-145, 3217047, 22035354.
8. Takemoto S, Shibamoto Y, Ayakawa S, Nagai A, Hayashi A, Ogino H, Baba F, Yanagi T, Sugie C, Kataoka H, Mimura M. Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer. Radiat Oncol 2012, 7:87-94. 10.1186/1748-717X-7-87, 3403958, 22691293.
9. Susil RC, McNutt TR, DeWeese TL, Song D. Effects of prostate-rectum separation on rectal dose from external beam radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76:1251-1258. 10.1016/j.ijrobp.2009.07.1679, 3115781, 19939577.
10. Pinkawa M, Corral NE, Caffaro M, Piroth MD, Holy R, Djukic V, Otto G, Schoth F, Eble MJ. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer. Radiother Oncol 2011, 100:436-41. 10.1016/j.radonc.2011.09.005, 21963289.
11. Pinkawa M, Piroth MD, Holy R, Escobar-Corral N, Caffaro M, Djukic V, Klotz J, Eble MJ. Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis. Strahlenther Onkol 2012, 10:917-25.
12. Noyes WR, Hosford CC, Schultz SE. Human collagen injections to reduce rectal dose during radiotherapy. Int J Radiat Oncol Biol Phys 2012, 82:1918-22. 10.1016/j.ijrobp.2011.02.034, 21514738.
13. Wachter S, Gerstner N, Dorner D, Goldner G, Colotto A, Wambersie A, . Pötter The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002, 52:91-100. 10.1016/S0360-3016(01)01821-1, 11777626, Pötter.
14. Levy Y, Paz A, Yosef RB, Corn BW, Vaisman B, Shuhat S, Domb AJ. Biodegradable inflatable balloon for reducing radiation adverse effects in prostate cancer. J Biomed Mater Res B Appl Biomater 2009, 91:855-867.
15. Ben-Yosef R, Paz A, Levy Y, Alani S, Muncher Y, Shohat S, Domb A, Corn B. A novel device for protecting rectum during prostate cancer irradiation: in vivo data on a large mammal model. J Urol 2009, 181:1401-1406. 10.1016/j.juro.2008.11.010, 19157458.
16. Cambria R, Jereczek-Fossa BA, Cattani F, Garibaldi C, Zerini D, Fodor C, Serafini F, Pedroli G, Orecchia R. Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer A comparison between dose-volume constraints and NTCP use. Strahlenther Onkol 2009, 185:384-389. 10.1007/s00066-009-1933-8, 19506822.
17. Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial. Int J Radiat Oncol Biol Phys 2010, 78:1081-1085. 10.1016/j.ijrobp.2009.09.015, 20207497.
18. Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010, 76(3):S123-9. 10.1016/j.ijrobp.2009.03.078, 3319467, 20171506.
19. Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Int J Radiat Oncol Biol Phys 2012, 82:235-41. 10.1016/j.ijrobp.2010.09.058, 21163587.
20. National Cancer Institute, Cancer Therapy Evaluation Program " Common Terminology Criteria for Adverse Events, version 3.0." 2003, http://ctep.cancer.gov/, National Cancer Institute, Cancer Therapy Evaluation Program.
21. Keita H, Diouf E, Tubach F, Brouwer T, Dahmani S, Mantz J, Desmonts JM. Predictive Factors of Early Postoperative Urinary Retention in the Post anesthesia Care Unit. Anesth Analg 2005, 101:592-596. 10.1213/01.ANE.0000159165.90094.40, 16037182.